Markerless dynamic tumor tracking (MDTT) radiotherapy using diaphragm as a surrogate for liver targets.

Journal

J Appl Clin Med Phys, 2024

Authors

Rostamzadeh M, Thomas S, Camborde ML, Karan T, Liu M, Ma R, Mestrovic A, Gill B, Tai I, Bergman A

BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.

Donate Today

Markerless dynamic tumor tracking (MDTT) radiotherapy using diaphragm as a surrogate for liver targets.

BC Cancer Research

Office of Research Administration

Cancer Control Research

Genome Sciences Centre

Terry Fox Laboratory

Molecular Oncology

Integrative Oncology

Lymphoid Cancer Research

Experimental Therapeutics

Clinical Research

Deeley Research Centre